- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Kazia Therapeutics Ltd ADR is a biotechnology business based in the US. Kazia Therapeutics Ltd ADR shares (KZIA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.02 – a decrease of 11.18% over the previous week.
What's in this guide?
- KZIA shares summary
- Compare share dealing platforms
- Is KZIA stock a buy or sell?
- Stock performance over time
- Can I short KZIA shares?
- Kazia Therapeutics Ltd ADR's financials
- How volatile are KZIA shares?
- Does Kazia Therapeutics Ltd ADR pay a dividend?
- Have KZIA shares ever split?
- Other common questions
Our top picks for where to buy Kazia Therapeutics Ltd ADR stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Kazia Therapeutics Ltd ADR stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – KZIA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Kazia Therapeutics Ltd ADR stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Kazia Therapeutics Ltd ADR stock price (NASDAQ: KZIA)
Use our graph to track the performance of KZIA stocks over time.Kazia Therapeutics Ltd ADR shares at a glance
Information last updated 2024-12-18.
| Latest market close | $3.02 |
|---|---|
| 52-week range | $1.87 - $15.80 |
| 50-day moving average | $4.97 |
| 200-day moving average | $3.79 |
| Wall St. target price | $19.15 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-6.44 |
Is it a good time to buy Kazia Therapeutics Ltd ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Kazia Therapeutics Ltd ADR price performance over time
Historical closes compared with the close of $3.02 from 2024-12-20
| 1 week (2024-12-16) | -9.31% |
|---|---|
| 1 month (2024-11-22) | -47.57% |
| 3 months (2024-09-23) | 803.11% |
| 6 months (2024-06-21) | 1,028.55% |
| 1 year (2023-12-22) | 638.03% |
|---|---|
| 2 years (2022-12-23) | -44.53% |
| 3 years (2021-12-23) | 83.9 |
| 5 years (2019-12-23) | 42.5 |
Kazia Therapeutics Ltd ADR financials
| Revenue TTM | $560 |
|---|---|
| Gross profit TTM | $555 |
| Return on assets TTM | -46.42% |
| Return on equity TTM | -186.37% |
| Profit margin | 0% |
| Book value | $2.00 |
| Market Capitalization | $12.4 million |
TTM: trailing 12 months
Kazia Therapeutics Ltd ADR share dividends
We're not expecting Kazia Therapeutics Ltd ADR to pay a dividend over the next 12 months.
Have Kazia Therapeutics Ltd ADR's shares ever split?
Kazia Therapeutics Ltd ADR's shares were split on a 1:10 basis on 27 October 2024 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Kazia Therapeutics Ltd ADR shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Kazia Therapeutics Ltd ADR shares which in turn could have impacted Kazia Therapeutics Ltd ADR's share price.
Kazia Therapeutics Ltd ADR share price volatility
Over the last 12 months, Kazia Therapeutics Ltd ADR's shares have ranged in value from as little as $1.866 up to $15.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kazia Therapeutics Ltd ADR's is 2.08. This would suggest that Kazia Therapeutics Ltd ADR's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Kazia Therapeutics Ltd ADR overview
Kazia Therapeutics Limited operates as an oncology-focused biotechnology company. The company's lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma. It also develops EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia. .
Frequently asked questions
What percentage of Kazia Therapeutics Ltd ADR is owned by institutions?Currently 7.06% of Kazia Therapeutics Ltd ADR shares are held by institutions. When does the fiscal year end for Kazia Therapeutics Ltd ADR?
Kazia Therapeutics Ltd ADR's fiscal year ends in June. Where is Kazia Therapeutics Ltd ADR based?
Kazia Therapeutics Ltd ADR's address is: Three International Towers, Sydney, NSW, Australia, 2000 What is Kazia Therapeutics Ltd ADR's ISIN number?
Kazia Therapeutics Ltd ADR's international securities identification number is: US48669G1058 What is Kazia Therapeutics Ltd ADR's CUSIP number?
Kazia Therapeutics Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 67010F103
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question